155 related articles for article (PubMed ID: 26239974)
1. Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.
Dumond JB; Yang KH; Kendrick R; Reddy YS; Kashuba AD; Troiani L; Bridges AS; Fiscus SA; Forrest A; Cohen MS
Antimicrob Agents Chemother; 2015 Oct; 59(10):6395-401. PubMed ID: 26239974
[TBL] [Abstract][Full Text] [Related]
2. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
Dumond JB; Reddy YS; Troiani L; Rodriguez JF; Bridges AS; Fiscus SA; Yuen GJ; Cohen MS; Kashuba AD
J Acquir Immune Defic Syndr; 2008 Jun; 48(2):156-62. PubMed ID: 18360288
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
Anderson PL; Zheng JH; King T; Bushman LR; Predhomme J; Meditz A; Gerber J; Fletcher CV
AIDS; 2007 Sep; 21(14):1849-54. PubMed ID: 17721092
[TBL] [Abstract][Full Text] [Related]
4. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
Rower JE; Meditz A; Gardner EM; Lichtenstein K; Predhomme J; Bushman LR; Klein B; Zheng JH; Mawhinney S; Anderson PL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3011-9. PubMed ID: 22391541
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
Rodriguez JF; Rodriguez JL; Santana J; García H; Rosario O
Antimicrob Agents Chemother; 2000 Nov; 44(11):3097-100. PubMed ID: 11036029
[TBL] [Abstract][Full Text] [Related]
8. Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
Bazzoli C; Bénech H; Rey E; Retout S; Salmon D; Duval X; Tréluyer JM; Mentré F;
Antimicrob Agents Chemother; 2011 Jul; 55(7):3423-31. PubMed ID: 21576446
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
[TBL] [Abstract][Full Text] [Related]
10. Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
Chen J; Flexner C; Liberman RG; Skipper PL; Louissaint NA; Tannenbaum SR; Hendrix CW; Fuchs EJ
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):593-9. PubMed ID: 23187888
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study.
Else LJ; Jackson A; Puls R; Hill A; Fahey P; Lin E; Amara A; Siccardi M; Watson V; Tjia J; Emery S; Khoo S; Back DJ; Boffito M
Antimicrob Agents Chemother; 2012 Mar; 56(3):1427-33. PubMed ID: 22183172
[TBL] [Abstract][Full Text] [Related]
12. Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors.
Hurwitz SJ; Schinazi RF
Antiviral Res; 2002 Nov; 56(2):115-27. PubMed ID: 12367718
[TBL] [Abstract][Full Text] [Related]
13. Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine.
Hurwitz SJ; Asif G; Schinazi RF
Antivir Chem Chemother; 2007; 18(6):329-41. PubMed ID: 18320937
[TBL] [Abstract][Full Text] [Related]
14. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
Flynn PM; Rodman J; Lindsey JC; Robbins B; Capparelli E; Knapp KM; Rodriguez JF; McNamara J; Serchuck L; Heckman B; Martinez J;
Antimicrob Agents Chemother; 2007 Oct; 51(10):3516-22. PubMed ID: 17664328
[TBL] [Abstract][Full Text] [Related]
15. Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens.
Hawkins T; Veikley W; St Claire RL; Guyer B; Clark N; Kearney BP
J Acquir Immune Defic Syndr; 2005 Aug; 39(4):406-11. PubMed ID: 16010161
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates.
Duan C; Poticha D; Stoeckli TC; Petropoulos CJ; Whitcomb JM; McHenry CS; Kuritzkes DR
J Infect Dis; 2001 Nov; 184(10):1336-40. PubMed ID: 11679926
[TBL] [Abstract][Full Text] [Related]
17. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
[TBL] [Abstract][Full Text] [Related]
18. Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry.
Font E; Rosario O; Santana J; García H; Sommadossi JP; Rodriguez JF
Antimicrob Agents Chemother; 1999 Dec; 43(12):2964-8. PubMed ID: 10582890
[TBL] [Abstract][Full Text] [Related]
19. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
Anderson PL; Kakuda TN; Kawle S; Fletcher CV
AIDS; 2003 Oct; 17(15):2159-68. PubMed ID: 14523272
[TBL] [Abstract][Full Text] [Related]
20. High Plasma Concentrations of Zidovudine (AZT) Do Not Parallel Intracellular Concentrations of AZT-Triphosphates in Infants During Prevention of Mother-to-Child HIV-1 Transmission.
Kinai E; Kato S; Hosokawa S; Sadatsuki M; Gatanaga H; Kikuchi Y; Lam NV; Ha do Q; Kinh NV; Liem NT; Oka S
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):246-53. PubMed ID: 26859826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
